REAL-WORLD DOSING AND ADHERENCE IN PATIENTS WITH MULTIPLE SCLEROSIS TREATED WITH NABIXIMOLS IN GERMANY

被引：0
|
作者：
Freilich, J. [1 ]
Rodriguez-Rey, Delclaux M. [2 ]
Spelman, T. [3 ]
Yeramaneni, S. [4 ]
Drachenberg, C. [4 ]
机构：
[1] Parexel Int, Stockholm, AB, Sweden
[2] Parexel Int, London, England
[3] Karolinska Inst, Stockholm, Sweden
[4] Jazz Pharmaceut, Palo Alto, CA USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
RWD86
引用
收藏
页码：S376 / S376
页数：1
相关论文
共 50 条
  • [1] REAL-WORLD RAAS INHIBITOR DOSING AND ADHERENCE IN PATIENTS ON PATIROMER
    Thakar, Charuhas
    Kammerer, Jennifer
    LaGuerre, Kevin
    Kleinman, Nathan
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 77 (04) : 657 - 657
  • [2] Multiple Sclerosis Patients Treated with Diroximel Fumarate in the Real-World Setting have High Rates of Persistence and Adherence
    Liseno, Jacob
    Lager, Brittney
    Miller, Catherine
    Shankar, Sai L.
    Mendoza, Jason P.
    Lewin, James B.
    NEUROLOGY, 2021, 96 (15)
  • [3] Multiple Sclerosis Patients Treated With Diroximel Fumarate in the Real-World Setting Have High Rates of Persistence and Adherence
    Jacob Liseno
    Brittney Lager
    Catherine Miller
    Sai L. Shankar
    Jason P. Mendoza
    James B. Lewin
    Neurology and Therapy, 2021, 10 : 349 - 360
  • [4] Multiple Sclerosis Patients Treated With Diroximel Fumarate in the Real-World Setting Have High Rates of Persistence and Adherence
    Liseno, Jacob
    Lager, Brittney
    Miller, Catherine
    Shankar, Sai L.
    Mendoza, Jason P.
    Lewin, James B.
    NEUROLOGY AND THERAPY, 2021, 10 (01) : 349 - 360
  • [5] Multiple Sclerosis Patients Treated with Diroximel Fumarate in the Real-World Setting have High Rates of Persistence and Adherence
    Liseno, J.
    Lager, B.
    Miller, C.
    Shankar, S. L.
    Mendoza, J. P.
    Lewin, J. B.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (1_SUPPL) : 94 - 94
  • [6] Real-world experience of secondary progressive multiple sclerosis patients treated with siponimod
    Totaro, Rocco
    Borriello, Giovanna
    Marinelli, Fabiana
    Bianco, Assunta
    Evangelista, Luana
    Mirabella, Massimiliano
    Cicia, Alessandra
    Marini, Carmine
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1240 - 1241
  • [7] Real-world persistence, adherence and treatment satisfaction in patients with relapsing-remitting multiple sclerosis treated with ocrelizumab for 2 years
    Trojano, Maria
    van Pesch, Vincent
    Alroughani, Raed
    Rovira Canellas, Alex
    Cutter, Gary
    Dzhenkova, Dima
    Hagenbuch, Niels
    Siadimas, Thanos
    Camerlingo, Sebastian
    Craveiro, Licinio
    Hobart, Jeremy
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1084 - 1085
  • [8] Real-world outcomes of siponimod in multiple sclerosis patients
    Tan, Hongmei
    Quan, Chao
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1129 - 1129
  • [9] Multiple sclerosis patients treated with diroximel fumarate over 1 year in the real-world setting have high rates of persistence and adherence
    Lager, B.
    Liseno, J.
    Miller, C.
    Shankar, S. L.
    Mendoza, J. P.
    Lewin, J. B.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 691 - 691
  • [10] Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis
    Brittney Lager
    Jacob Liseno
    Ivan Božin
    Sarah M. England
    Sai L. Shankar
    Jason P. Mendoza
    James B. Lewin
    Neurology and Therapy, 2023, 12 (1) : 145 - 159
12345